Q4 2025 · 13F-HR
SECTORAL ASSET MANAGEMENT INCholdings as filed
Filed 2026-02-09 · accession 0001104659-26-011921
$124.8M
Reported value
74
Positions
2025-12-31
Period end
The Brief · SECTORAL ASSET MANAGEMENT INC · Q4 2025
AI · grounded in 13F
SECTORAL ASSET MANAGEMENT INC established a new position in EVOMMUNE INC valued at $10.08M. The fund also opened a new position in COGT for $1.16M and increased its holdings in JNJ by 32.68%. On the sell side, the fund closed its positions in ANAB for -$5.96M, BCAX for -$4.21M, and SLDB for -$3.91M.
Holdings as filed
| CUSIP | Ticker | Issuer | Value | % port. | Shares | Class | Voting |
|---|---|---|---|---|---|---|---|
| 30054Y107 | EVMN | EVOMMUNE INC | $10.1M | 8.08% | 589,005 | Common | SOLE |
| 21217B100 | CTNM | CONTINEUM THERAPEUTICS | $9.2M | 7.34% | 800,787 | Common | SOLE |
| 532457108 | LLY | ELI LILLY & CO | $7.8M | 6.27% | 7,276 | Common | SOLE |
| 82537J108 | SI | SHOULDER INNOVATIONS | $7.0M | 5.64% | 492,435 | Common | SOLE |
| 91324P102 | UNH | UNITEDHEALTH GRP INC | $4.5M | 3.60% | 13,595 | Common | SOLE |
| 031162100 | AMGN | AMGEN INC | $4.3M | 3.43% | 13,070 | Common | SOLE |
| 478160104 | JNJ | JOHNSON & JOHNSON | $4.2M | 3.37% | 20,300 | Common | SOLE |
| 00287Y109 | ABBV | ABBVIE INC | $3.8M | 3.08% | 16,800 | Common | SOLE |
| 92532F100 | VRTX | VERTEX PHARMA | $3.6M | 2.91% | 8,005 | Common | SOLE |
| 002824100 | ABT | ABBOTT LABS | $2.9M | 2.36% | 23,498 | Common | SOLE |
| 75886F107 | REGN | REGENERON PHARMCTCLS | $2.9M | 2.30% | 3,715 | Common | SOLE |
| 46120E602 | ISRG | INTUITIVE SURGIC INC | $2.7M | 2.20% | 4,850 | Common | SOLE |
| 101137107 | BSX | BOSTON SCIENTIFIC | $2.6M | 2.11% | 27,626 | Common | SOLE |
| 04016X101 | ARGX | ARGENX SE SPN ADR | $2.4M | 1.95% | 2,894 | Common | SOLE |
| 235851102 | DHR | DANAHER CORP | $2.4M | 1.94% | 10,575 | Common | SOLE |
| 863667101 | SYK | STRYKER CORP | $2.3M | 1.85% | 6,550 | Common | SOLE |
| 883556102 | TMO | THERMO FISHER SCIENTIFIC | $2.3M | 1.81% | 3,900 | Common | SOLE |
| 58933Y105 | MRK | MERCK & CO INC | $2.3M | 1.81% | 21,400 | Common | SOLE |
| 375558103 | GILD | GILEAD SCIENCES INC | $2.2M | 1.76% | 17,885 | Common | SOLE |
| 457669307 | INSM | INSMED INC | $1.9M | 1.56% | 11,182 | Common | SOLE |
| 252131107 | DXCM | DEXCOM INC | $1.9M | 1.53% | 28,700 | Common | SOLE |
| 92337R101 | VERA | VERA THERAPEUTICS | $1.9M | 1.50% | 36,858 | Common | SOLE |
| 86366E106 | GPCR | STRUCTURE THERAPEUTICS | $1.7M | 1.33% | 23,872 | Common | SOLE |
| 09075V102 | BNTX | BIONTECH SE | $1.6M | 1.31% | 17,218 | Common | SOLE |
| 28176E108 | EW | EDWARDS LIFESCIENCE | $1.5M | 1.18% | 17,250 | Common | SOLE |
| 046353108 | AZNN | ASTRAZENECA | $1.4M | 1.12% | 15,232 | Common | SOLE |
| 86627T108 | SMMT | SUMMIT THERAPEUTICS | $1.4M | 1.12% | 79,625 | Common | SOLE |
| 03969F109 | RCUS | ARCUS BIOSCIENCES | $1.4M | 1.09% | 56,945 | Common | SOLE |
| 87164F105 | SNDX | SYNDAX PHARMACEUTICALS | $1.3M | 1.03% | 61,200 | Common | SOLE |
| 87650L103 | TARS | TARSUS PHARMACEUTICAL | $1.2M | 0.97% | 14,740 | Common | SOLE |
| 02043Q107 | ALNY | ALNYLAM PHARMACEUTICALS INC | $1.2M | 0.95% | 2,990 | Common | SOLE |
| 75383L102 | RAPP | RAPPORT THERAPEUTICS | $1.2M | 0.95% | 38,925 | Common | SOLE |
| 19240Q201 | COGT | COGENT BIOSCIENCES INC | $1.2M | 0.93% | 32,685 | Common | SOLE |
| 603170101 | MLYS | MINERALYS THERAPEUTICS | $1.1M | 0.92% | 31,625 | Common | SOLE |
| 89532M101 | TRVI | TREVI THERAPEUTIC INC | $1.1M | 0.85% | 84,255 | Common | SOLE |
| G76279101 | ROIV | ROIVANT SCIENCES LTD | $984,030 | 0.79% | 45,347 | Common | SOLE |
| 878972108 | TECX | TECTONIC THERAPEUTICS | $881,439 | 0.71% | 42,255 | Common | SOLE |
| 92332V107 | VTYXUSD | VENTYX BIOSCIENCES | $875,413 | 0.70% | 96,945 | Common | SOLE |
| 10806X102 | BBIO | BRIDGEBIO PHARMA | $854,393 | 0.68% | 11,170 | Common | SOLE |
| 91307C102 | UTHR | UNITED THERAPEUTICS | $839,532 | 0.67% | 1,723 | Common | SOLE |
| 10170A100 | BOLD | BOUNDLESS BIO INC | $814,289 | 0.65% | 678,574 | Common | SOLE |
| 07725L102 | ONC | BEONE MEDICINES LTD | $809,654 | 0.65% | 2,665 | Common | SOLE |
| 750491102 | RDNT | RADNET INC | $784,850 | 0.63% | 11,000 | Common | SOLE |
| 04272N102 | AVBP | ARRIVENT BIOPHARMA | $769,691 | 0.62% | 38,255 | Common | SOLE |
| N90064101 | QURE | UNIQURE N.V. | $731,899 | 0.59% | 30,585 | Common | SOLE |
| 04351P101 | ASNDUSD | ASCENDIS PHARMA | $693,883 | 0.56% | 3,254 | Common | SOLE |
| 52635N103 | LENZ | LENZ THERAPEUTICS INC | $680,000 | 0.55% | 42,500 | Common | SOLE |
| 717081103 | PFE | PFIZER INC | $676,035 | 0.54% | 27,150 | Common | SOLE |
| 457730109 | INSP | INSPIRE MED SYS INC | $664,056 | 0.53% | 7,200 | Common | SOLE |
| 462222100 | IONS | IONIS PHARMACEUTICAL | $661,755 | 0.53% | 8,365 | Common | SOLE |
| N44445109 | IMTX | IMMATICS NV | $661,658 | 0.53% | 63,015 | Common | SOLE |
| 433313103 | HNGE | HINGE HEALTH INC | $659,869 | 0.53% | 14,206 | Common | SOLE |
| 09061G101 | BMRN | BIOMARIN PHARMACEUTICAL INC | $646,599 | 0.52% | 10,880 | Common | SOLE |
| 01625V104 | ALHC | ALIGNMENT HEALTHCARE | $622,125 | 0.50% | 31,500 | Common | SOLE |
| 03152W109 | AM6 | AMICUS THERAPEUTICS | $616,592 | 0.49% | 43,300 | Common | SOLE |
| 74276R102 | PRVA | PRIVIA HEALTH GROUP | $616,460 | 0.49% | 26,000 | Common | SOLE |
| 14280C105 | CARL | CARLSMED INC | $589,095 | 0.47% | 47,700 | Common | SOLE |
| 69366J200 | PTCT | PTC THERAPEUTICS | $586,031 | 0.47% | 7,715 | Common | SOLE |
| 68170A108 | OMDA | OMADA HEALTH INC | $575,970 | 0.46% | 36,500 | Common | SOLE |
| 640268306 | NKTR | NEKTAR THERAPEUTICS | $570,146 | 0.46% | 13,485 | Common | SOLE |
| 50127T109 | KURA | KURA ONCOLOGY | $562,203 | 0.45% | 54,110 | Common | SOLE |
| 64125C109 | NBIX | NEUROCRINE BIOSCIENCES | $379,395 | 0.30% | 2,675 | Common | SOLE |
| 09062X103 | BIIB | BIOGEN INC | $379,259 | 0.30% | 2,155 | Common | SOLE |
| 23282W605 | CYTK | CYTOKINETICS INC | $374,441 | 0.30% | 5,893 | Common | SOLE |
| G50871105 | JAZZ | JAZZ PHARMA PLC | $348,330 | 0.28% | 2,049 | Common | SOLE |
| 82835W108 | SPRY | ARS PHARMACEUTICALS | $347,205 | 0.28% | 29,803 | Common | SOLE |
| G7709Q104 | RPRX | ROYALTY PHARMA PLC | $327,281 | 0.26% | 8,470 | Common | SOLE |
| 452327109 | ILMN | ILLUMINA INC | $324,227 | 0.26% | 2,472 | Common | SOLE |
| 05464T104 | AXSM | AXSOME THERAPEUTICS | $317,794 | 0.25% | 1,740 | Common | SOLE |
| 45337C102 | INCY | INCYTE CORPORATION | $271,618 | 0.22% | 2,750 | Common | SOLE |
| 88023B103 | TEM | TEMPUS AI INC | $265,725 | 0.21% | 4,500 | Common | SOLE |
| 558868105 | MDGL | MADRIGAL PHARMA | $204,984 | 0.16% | 352 | Common | SOLE |
| 68622P109 | ORIC | ORIC PHARMACEUTICALS | $183,886 | 0.15% | 22,480 | Common | SOLE |
| 60770K107 | MRNA | MODERNA INC | $147,598 | 0.12% | 5,005 | Common | SOLE |
Source: SEC EDGAR · raw 13F holdings as filed. The Class column shows the option type when reported (Put/Call) or Common when the issuer's equity is held directly. 13F discloses long positions only.